New Jersey S2067 mandates that prescription drug services under the Medicaid program be administered via a fee-for-service system.

New Jersey S2067 shifts the administration of prescription drug services under the Medicaid program from a managed care system to a fee-for-service delivery system. This change is expected to generate savings for the state and improve access to prescription drugs for Medicaid patients. The bill also outlines specific reimbursement calculations for various types of drugs, including brand name, generic, specialty, and clotting factors.

New Jersey S2067 mandates that prescription drug services under the Medicaid program be administered via a fee-for-service system.

New Jersey S2067 shifts the administration of prescription drug services under the Medicaid program from a managed care system to a fee-for-service delivery system. This change is expected to generate savings for the state and improve access to prescription drugs for Medicaid patients. The bill also outlines specific reimbursement calculations for various types of drugs, including brand name, generic, specialty, and clotting factors.